Bell's palsy and SARS-CoV-2 vaccines
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Ozonoff et al. suggested a possible association between the BNT162b2 and mRNA-1273 vaccines and Bell's palsy and estimated a rate ratio of approximately 7.0.
“Ozonoff et al.28 suggested a possible association between these vaccines and Bell’s palsy and estimated a rate ratio of approximately 7.0.”
From Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting (2021) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland
Mütsch, M., Zhou, W., Rhodes, P., Bopp, M., Chen, R. T., Linder, T. E., Spyr, C., & Steffen, R. P. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030595 · Cited by 918 · see citing works
Bardage, C., Persson, I., Örtqvist, Å., Bergman, U., Ludvigsson, J. F., & Granath, F. (2011) · BMJ · doi:10.1136/bmj.d5956 · Cited by 190 · see citing works
Zhou, W., Pool, V., Destefano, F. R., Iskander, J. K., Haber, P., & Chen, R. T. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.998 · Cited by 85 · see citing works
Do Vaccines Have a Role as a Cause of Autoimmune Neurological Syndromes?
Principi, N., & Esposito, S. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00361 · Cited by 54 · see citing works
Knipe, D. M., Levy, O., Fitzgerald, K. A., & Mühlberger, E. (2020) · Science · doi:10.1126/science.abf0357 · Cited by 37 · see citing works
Self-citationHuang, W., Huang, W., Huang, W., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.013 · Cited by 36 · see citing works
Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-Olds
Tseng, H. F., Sy, L. S., Ackerson, B. K., Hechter, R. C., Tartof, S. Y., Haag, M. D. M., Slezak, J. M., Luo, Y., Fischetti, C. A., Takhar, H. S., et al. (2016) · PEDIATRICS · doi:10.1542/peds.2016-2084 · Cited by 27 · see citing works
LETTER: Bell's Palsy: A Rare Complication of Interferon Therapy for Hepatitis C
Hwang, I., Calvit, T. B., Cash, B. D., & Holtzmuller, K. C. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000026389.56819.0c · Cited by 24 · see citing works
Hansen, J. R., Zhang, L., Klein, N. P., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.09.032 · Cited by 15 · see citing works
Bell’s palsy during interferon alpha 2a treatment in a case with Behçet uveitis
Yalçındağ, F. N., & Alay, C. (2013) · F1000Research · doi:10.12688/f1000research.2-245.v1 · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., Hernán, M. A., Lipsitch, M., Kohane, I., Netzer, D., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2110475 · Cited by 1,027 · see citing works
Otero-Losada, M., Petrovsky, N., Alami, A., Crispo, J. A., Mattison, D., Capani, F., Goetz, C., Krewski, D., & Perez-Lloret, S. (2023) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2120607 · Cited by 22 · see citing works
van der Boom, M. D. X., van Eekeren, R., & van Hunsel, F. P. A. M. (2023) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5610 · Cited by 11 · see citing works
- Authors
- Ozonoff, A., Nanishi, E., & Levy, O.
- Affiliations
- Boston Children's Hospital (US)
- Broad Institute (US)
- Corresponding author
- Levy, Ofer
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 21
- Issue
- 4
- Pages
- 450-452
- ISSN
- 1473-3099 (ISSN-L)
- PMC
- PMC7906673
- OpenAlex
- W3131650037
- Cited by
- 158
- References
- 10
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 14 · 2023: 38 · 2022: 52 · 2021: 43
- FWCI
- 17.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The Lancet Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases
- Topics
- Health Sciences › Medicine › Neurology › Facial Nerve Paralysis Treatment and Research
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- Bell's palsy, COVID-19 vaccines, mRNA vaccines, vaccine safety, adverse events
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Vaccines, Humans, Influenza Vaccines, United States, United States Food and Drug Administration, Bell Palsy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
